Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
McKesson
Cantor Fitzgerald
Argus Health
QuintilesIMS
AstraZeneca

Generated: March 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Trehalose

« Back to Dashboard

US Patents for Trehalose

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Trehalose ➤ Sign Up Compounds alpha v beta 6 integrin antagonists GlaxoSmithKline Intellectual Property Development Limited (Brentford, Middlesex, GB) ➤ Sign Up
Trehalose ➤ Sign Up Salt of cephalosporin derivative, its crystalline solid and a method of manufacturing thereof Shionogi & Co., Ltd. (Osaka, JP) ➤ Sign Up
Trehalose ➤ Sign Up Compositions and methods for treating Dengue virus infection The J. David Gladstone Institutes (San Francisco, CA) The Regents of the University of California (Oakland, CA) ➤ Sign Up
Trehalose ➤ Sign Up Method of reducing blood glucose by administering RON agonists GENENTECH, INC. (South San Francisco, CA) ➤ Sign Up
Trehalose ➤ Sign Up Expression cassettes derived from maize Syngenta Participations AG (Basel, CH) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Trehalose

Drugname Country Document Number Estimated Expiration Related US Patent
Trehalose Australia 2015320874 2034-09-26 ➤ Sign Up
Trehalose Brazil 112017006240 2034-09-26 ➤ Sign Up
Trehalose Canada 2962319 2034-09-26 ➤ Sign Up
Trehalose China 107074850 2034-09-26 ➤ Sign Up
Trehalose European Patent Office 3197895 2034-09-26 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Julphar
Express Scripts
Baxter
Cipla
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.